Literature DB >> 21208164

The start of a new era for stroke treatment: mechanical thrombectomy devices.

Sihame Benmira1, Zuliana K Banda, Vish Bhattacharya.   

Abstract

Stroke is a major cause of mortality in the U.K. accounting for 53,000 deaths every year. There are few options for the treatment of acute ischemic stroke and recombinant tissue plasminogen activator (rt-PA) remains the only approved and currently available thrombolytic therapy given within the first 3 hours after symptom onset. Mechanical thrombectomy is a promising new treatment modality for patients who are ineligible for or failing intravenous rt-PA, or presenting beyond the narrow 3-hour therapeutic window, and emerged with the development of the Merci retrieval system. A number of devices are now available and can be divided into two major subgroups according to their mode of action. Those using a proximal approach such as aspiration devices (Penumbra system) act by applying a vacuum to the proximal aspect of the thrombus whereas distal devices (Merci retrieval system, Phenox clot retriever, and Catch device) such as coil-like and basket-like devices are advanced through the thrombus thereby contacting its distal aspect. In this review, we discuss the procedure and technique, as well as evidence associated with four mechanical retrieval systems currently available: the Merci Retriever System, the Penumbra system, the Catch device, and the Phenox clot retriever. We also consider potentialnovel approaches for stroke treatment including waterjet thrombectomy and laser recanalization.

Entities:  

Mesh:

Year:  2011        PMID: 21208164     DOI: 10.2174/156720211794520242

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  3 in total

1.  Safety and efficacy of the Aperio thrombectomy device when compared to the Solitaire AB/FR and the Revive devices in a pulsatile flow system.

Authors:  Mahdi Saleh; John Nathan Spence; Sanjeev Nayak; Gillian Pearce; Christopher Tennuci; Christine Roffe
Journal:  Am J Cardiovasc Dis       Date:  2012-10-25

2.  [Industry-funded therapy studies: what is in the pipeline?].

Authors:  P D Schellinger; M Köhrmann; J Röther
Journal:  Nervenarzt       Date:  2012-10       Impact factor: 1.214

Review 3.  The evolution of technology.

Authors:  Jeffrey L Saver
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.